French Cohort of Myocardial Infarction Evaluation

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Over the last two decades, considerable progress has been made in the management of Acute Myocardial Infarction (AMI), both in the acute phase and in monitoring beyond the hospital phase. Nevertheless, the evolution of care practices and their impact on the mid- and long-term prognosis of patients admitted to the intensive care unit for acute myocardial infarction remain relatively little studied exhaustively. The aim of this study is to assess the profile of AMI patients, their management and follow-up in order to evaluate the relationship between these factors and outcomes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Myocardial infarction (MI) within 48h of symptom onset, characterized by the typical increased or fall of troponin (or CPKMB) associated with at least one of the following elements :

• Symptoms compatible with myocardial ischemia

• Appearance of pathological Q waves

• ST- T changes compatible with myocardial ischemia (ST segment elevation or depression, T-wave inversion)

• Written consent.

• Covered by French medical insurance (Sécurité Sociale)

Locations
Other Locations
France
Hôpital Bichat, AP-HP
RECRUITING
Paris
Contact Information
Primary
Tabassome SIMON
tabassome.simon@aphp.fr
01 40 01 13 93
Backup
Philippe Gabriel STEG
gabriel.steg@aphp.fr
01 40 25 80 80
Time Frame
Start Date: 2019-03-11
Estimated Completion Date: 2049-03-22
Participants
Target number of participants: 30000
Treatments
Myocardial infarction
As it is an observational study, no intervention is planned. However, nested clinical interventional trials are planned for which a specific registration will be done
Related Therapeutic Areas
Sponsors
Leads: Assistance Publique - Hôpitaux de Paris
Collaborators: Novartis

This content was sourced from clinicaltrials.gov